CHU "3D BIOPRINTING SOLYUSHENS", Moscow

Economic indicators

Net profit (RAS) of CHU 3D BIOPRINTING SOLYUSHENS dropped in 2023 by 35.47% to 393.00 thousand RUB from 609.00 thousand RUB over the same period in 2022, the company informed.

Revenue increased in the accounting period by 33.75% to 1.07 million RUB from 800.00 thousand RUB over 2022; sales profit fell by 39.38% to 485.00 thousand RUB from 800.00 thousand RUB.

Net profit (RAS) of CHU 3D BIOPRINTING SOLYUSHENS grew over 2022 by 22.04% to 609.00 thousand RUB from 499.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 33.33% to 800.00 thousand RUB from 1.20 million RUB in 2021; sales profit went up 1.64 times to 800.00 thousand RUB from 487.00 thousand RUB.

Net profit (RAS) of CHU 3D BIOPRINTING SOLYUSHENS made up 499.00 thousand RUB over 2021 compared to net loss of 1.84 million RUB over 2020, the company informed.

Sales profit made up 487.00 thousand RUB compared to sales loss of 1.84 million RUB.

Net loss (RAS) of CHU 3D BIOPRINTING SOLYUSHENS dropped over 2020 by 19.65% to 1.84 million RUB from 2.30 million RUB KAgent.Entities.Balance, the company informed.

Sales loss decreased by 19.65% to 1.84 million RUB from 2.30 million RUB.

Net loss (RAS) of CHU 3D BIOPRINTING SOLYUSHENS increased by 11.52% to 2.30 million RUB from 2.06 million RUB over 2018, the company informed.

Sales loss grew by 11.52% to 2.30 million RUB from 2.06 million RUB.

Companies in the region

• GSK N 269
• 21 VEK
• 10 KVARTAL
• CHOP ACHSK
• TD KOMFORT